KIF20A and colorectal carcinoma: Yang et al. found that high expression of KIF20A in CRC cells was associated with oxaliplatin resistance, and that resistance to oxaliplatin in CRC could be overcome by disrupting the KIF20A/NUAK1/PP1β/GPX4 pathway (Yang C. et al., 2021).